Preoperative Genicular Radiofrequency and Functional Outcomes After Total Knee Arthroplasty

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAnesthesiology department Iris South Hospitals

About this trial

Knee osteoarthritis (OA) is a degenerative joint disease characterized by progressive cartilage wear, leading to pain, stiffness, and joint swelling. It is highly prevalent in aging populations and is strongly associated with obesity and previous joint injury. OA affects millions of individuals worldwide, with incidence and prevalence increasing markedly with age and resulting in significant functional disability

The primary therapeutic goals in the management of knee osteoarthritis are pain reduction and improvement of joint mobility.

Total knee arthroplasty is considered one of the most effective surgical interventions for relieving pain and restoring function in patients with severe knee osteoarthritis. Nevertheless, residual pain and limited functional improvement remain the most frequent causes of patient dissatisfaction following TKA

Genicular nerve radiofrequency ablation (GNRFA) has emerged as an innovative treatment option for symptomatic knee osteoarthritis. This technique has been shown to reduce pain and improve function, with clinical benefits often observed as early as one week after treatment. GNRFA consistently provides short-term pain relief (3 to 6 months) and, in some cases, longer-lasting benefits.

The hypothesis tested in this study is whether GNRFA performed at least two weeks preoperatively can reduce postoperative pain and improve postoperative function.

Eligibility criteria

Qualifiers

Age between 18 and 60

Elective total knee arthroplasty

2 to 6 weeks before the procedure

BMI > 35

Disqualifiers

Previous prosthetic surgery on the same knee (i.e. redo surgery, open reduction internal fixation, knee hemiarthroplasty)

Major psychiatric disorder (i.e. major depression, schizophrenia)

Patient refusal

Inability to communicate with the patient and obtain informed consent

Trial design

Treatments tested in this trial

  • Radiofrequency ablation of the genicular nerve, 42 degrees Celsius for 120 seconds

Treatment groups

44 Participants
are divided into 2 treatment groups